A retrospective review of rattlesnake bites in 100 children

Norberto Sotelo-Cruz1, Norberto Gómez-Rivera2

  • 1Department of Medicine and Health Sciences, University of Sonora, Children's Hospital of the State of Sonora (HIES), Hermosillo, Sonora, Mexico - nsotelo51@gmail.com.

Minerva Pediatrica
|February 10, 2017
PubMed

Insights

Pediatric rattlesnake bites are more common in males and young children, often occurring in rural areas during summer. F(Ab')2 therapy significantly reduced hospitalization time for snakebite treatment.

Area of Science:

  • Pediatric Toxicology
  • Herpetology
  • Clinical Medicine

Background:

  • This study reviews clinical features and treatment of pediatric rattlesnake bites.
  • Focuses on understanding the epidemiology and outcomes of snakebites in children.

Purpose of the Study:

  • To analyze clinical characteristics and treatment outcomes of children hospitalized for rattlesnake envenomation.
  • To evaluate the effectiveness of different antivenom treatments over time.

Main Methods:

  • Retrospective review of 100 clinical records of children with rattlesnake bites.
  • Analysis of variables including demographics, bite circumstances, clinical signs, envenomation grade, complications, and treatment.

Main Results:

  • Pediatric rattlesnake bites predominantly affected males (59%) and children under 5 (37%), often in rural summer settings.
  • F(Ab rading_sign)2 antivenom therapy (1997-2014) significantly reduced hospitalization duration compared to earlier treatments.
  • Hematological complications were frequent, with wound infections (26%) and neurological symptoms (24%) noted; mortality was 1%.

Conclusions:

  • Rattlesnake bites in Mexico are less common than other Crotalidae species, with hematological complications being more frequent.
  • F(Ab rading_sign)2 therapy is identified as the optimal treatment for pediatric rattlesnake envenomation.
  • No recurrent phenomena were observed in the studied cases.
Abstract

Related Concept Videos